Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02948647 · ClinicalTrials.gov registry record · NA
Healthy Eating Through Reduction Of Excess Sugar
A NA study of NAFLD, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 113
- Enrollment target
- 2
- Study locations
NCT02948647 is a NA study of NAFLD that has completed, run by University of Southern California. The registered enrollment target is 113 participants, below the 161-participant average among 26 other NAFLD trials with a reported enrollment target (30% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02948647, a NA study of NAFLD, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to determine the effect of dietary sugar reduction in obese children and examine whether there are differential effects based on genotype of a single amino acid substitution in the PNPLA3 gene that is highly prevalent in Hispanics and associated with significantly elevated liver fat.
Conditions Studied
Interventions
- OTHER Standard of care plus sugar-reduction education
Study Locations (2)
California
- Children's Hospital Los Angeles - Los Angeles
- Diabetes & Obesity Research Institute - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2016-11 |
| Est. Completion | 2021-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02948647
The ClinicalTrials.gov registry entry for NCT02948647 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 161-participant average among 26 other NAFLD trials with a reported enrollment target (30% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with NAFLD appearing as the primary indexed condition, and to 1 intervention - of which Standard of care plus sugar-reduction education is the first listed.
NCT02948647 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02948647 about?
NCT02948647 is a clinical study titled "Healthy Eating Through Reduction Of Excess Sugar". The purpose of the study is to determine the effect of dietary sugar reduction in obese children and examine whether there are differential effects based on genotype of a single amino acid substitution in the PNPLA3 gene that is highly prevalent in Hispanics and associated with significantly elevate...
What is the current status of trial NCT02948647?
This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2016-11. Estimated completion is 2021-11.
What conditions does trial NCT02948647 study?
This clinical trial studies the following conditions: NAFLD.
What interventions are being tested in trial NCT02948647?
The interventions under investigation include: Standard of care plus sugar-reduction education (OTHER).
Who is sponsoring clinical trial NCT02948647?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02948647 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NAFLD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reversal of Lipid-Induced Insulin Resistance
RECRUITING · NA
-
NAFLD Clinical Care Pathway
RECRUITING · NA
-
NASH AMPK Exercise Dosing (AMPED) Trial
RECRUITING · NA
-
Effect of VLCD on the Reduction of Liver Steatosis and Fibrosis in Subjects With Obesity and NAFLD
ACTIVE NOT RECRUITING · NA
-
An Imaging-based Quantitative Biomarker Assay for NAFLD in Children
ACTIVE NOT RECRUITING · NA
-
The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study)
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.